Chang T M
Artificial Cells and Organs Research Center, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
Artif Organs. 1992 Feb;16(1):71-4. doi: 10.1111/j.1525-1594.1992.tb00270.x.
Artificial liver support requires more than a detoxification system. We have investigated additional approaches. Microencapsulated hepatocytes increased the survival time of fulminant hepatic failure (FHF) rats. They also lowered the bilirubin in Gunn rats. Xenograft of microencapsulated rat hepatocytes into mice are immunoisolated. The viability of hepatocyte increased from 62 to 100% after 29 days. This is because of accumulation of a hepatic stimulatory factor (> 100,000 D) secreted by the hepatocytes in the artificial cells. A novel two-step method of cell encapsulation greatly improved immunoisolation and biocompatibility. Other metabolic approaches included a multienzyme system for conversion of ammonia to essential amino acid, and removal of bilirubin.
人工肝支持系统所需的不仅仅是一个解毒系统。我们已经研究了其他方法。微囊化肝细胞可延长暴发性肝衰竭(FHF)大鼠的存活时间,还能降低Gunn大鼠的胆红素水平。将微囊化大鼠肝细胞异种移植到小鼠体内可实现免疫隔离。29天后,肝细胞的活力从62%提高到了100%。这是因为人工细胞中肝细胞分泌的一种肝刺激因子(>100,000 D)有所积累。一种新颖的两步法细胞包封技术极大地改善了免疫隔离和生物相容性。其他代谢方法包括将氨转化为必需氨基酸的多酶系统以及胆红素清除。